Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
wolf-screen-ratio-mammosphere-adherent | 0.949 | 4.70e-16 | 1.82e-03 | 3.21e-02 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
RPA2 | 6118 | 98 | 1.250 | 1.151 | 69 | Yes | - |
[ PLA2G4A ] | 5321 | 1 | -0.137 | 0.949 | 46 | - | Yes |
CDC16 | 8881 | 25 | 0.950 | 1.020 | 80 | Yes | - |
RBX1 | 9978 | 97 | 1.185 | 1.151 | 139 | Yes | - |
PSMD3 | 5709 | 57 | 0.986 | 1.106 | 146 | Yes | - |
PSMB7 | 5695 | 48 | 0.982 | 1.052 | 57 | Yes | - |
PSMA1 | 5682 | 61 | 0.996 | 1.052 | 123 | Yes | - |
PSMD11 | 5717 | 121 | 1.095 | 1.106 | 183 | Yes | - |
ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - |
ITGAV | 3685 | 2 | 0.556 | 0.949 | 37 | - | - |
HSPD1 | 3329 | 35 | 0.913 | 1.035 | 286 | Yes | - |
CASP8 | 841 | 8 | 0.804 | 1.041 | 141 | - | - |
RPSA | 3921 | 156 | 1.327 | 1.151 | 152 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
PSMA1 | 5682 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMD3 | 5709 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
CASP8 | 841 | PLA2G4A | 5321 | pp | -- | int.I2D: INNATEDB |
RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
PSMA1 | 5682 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
ITGAV | 3685 | PLA2G4A | 5321 | pp | -- | int.I2D: INNATEDB |
PSMA1 | 5682 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastLow, Krogan_Core, MINT_Yeast |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB7 | 5695 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PLA2G4A | 5321 | pp | -- | int.I2D: INNATEDB |
ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | CDC16 | 8881 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | PSMA1 | 5682 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | RPSA | 3921 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | HSPD1 | 3329 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.99e-09 | 2.87e-05 | 6.415 | 5 | 22 | 65 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.91e-09 | 4.19e-05 | 6.308 | 5 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.36e-09 | 4.84e-05 | 6.268 | 5 | 20 | 72 |
GO:0016032 | viral process | 3.66e-09 | 5.28e-05 | 4.055 | 8 | 55 | 534 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.86e-09 | 5.57e-05 | 6.228 | 5 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.14e-09 | 5.97e-05 | 6.209 | 5 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.39e-09 | 7.78e-05 | 6.134 | 5 | 23 | 79 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.17e-08 | 1.69e-04 | 5.914 | 5 | 21 | 92 |
GO:0006521 | regulation of cellular amino acid metabolic process | 8.93e-08 | 1.29e-03 | 6.472 | 4 | 17 | 50 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.32e-07 | 1.91e-03 | 5.218 | 5 | 32 | 149 |
GO:0000502 | proteasome complex | 1.64e-07 | 2.36e-03 | 6.258 | 4 | 17 | 58 |
GO:0005829 | cytosol | 2.26e-07 | 3.27e-03 | 2.290 | 11 | 132 | 2496 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.45e-07 | 3.53e-03 | 6.116 | 4 | 19 | 64 |
GO:0000278 | mitotic cell cycle | 5.58e-07 | 8.05e-03 | 4.090 | 6 | 48 | 391 |
GO:0005654 | nucleoplasm | 8.95e-07 | 1.29e-02 | 3.036 | 8 | 76 | 1082 |
GO:0016071 | mRNA metabolic process | 9.83e-07 | 1.42e-02 | 4.637 | 5 | 31 | 223 |
GO:0016070 | RNA metabolic process | 1.63e-06 | 2.35e-02 | 4.489 | 5 | 32 | 247 |
GO:0000209 | protein polyubiquitination | 2.69e-06 | 3.87e-02 | 5.258 | 4 | 20 | 116 |
GO:0042981 | regulation of apoptotic process | 7.47e-06 | 1.08e-01 | 4.887 | 4 | 24 | 150 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.25e-05 | 1.81e-01 | 4.698 | 4 | 20 | 171 |
GO:0043066 | negative regulation of apoptotic process | 2.27e-05 | 3.28e-01 | 3.710 | 5 | 31 | 424 |
GO:0005838 | proteasome regulatory particle | 4.92e-05 | 7.10e-01 | 7.531 | 2 | 7 | 12 |
GO:0006915 | apoptotic process | 8.25e-05 | 1.00e+00 | 3.321 | 5 | 33 | 555 |
GO:0022624 | proteasome accessory complex | 1.01e-04 | 1.00e+00 | 7.028 | 2 | 8 | 17 |
GO:0005839 | proteasome core complex | 1.14e-04 | 1.00e+00 | 6.946 | 2 | 8 | 18 |
GO:0004298 | threonine-type endopeptidase activity | 1.27e-04 | 1.00e+00 | 6.868 | 2 | 8 | 19 |
GO:0010467 | gene expression | 1.99e-04 | 1.00e+00 | 3.052 | 5 | 59 | 669 |
GO:0042113 | B cell activation | 2.22e-04 | 1.00e+00 | 6.472 | 2 | 2 | 25 |
GO:0070062 | extracellular vesicular exosome | 3.39e-04 | 1.00e+00 | 1.887 | 8 | 104 | 2400 |
GO:0031625 | ubiquitin protein ligase binding | 4.83e-04 | 1.00e+00 | 4.225 | 3 | 14 | 178 |
GO:0042110 | T cell activation | 6.33e-04 | 1.00e+00 | 5.723 | 2 | 3 | 42 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0070243 | regulation of thymocyte apoptotic process | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0030690 | Noc1p-Noc2p complex | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:2000425 | regulation of apoptotic cell clearance | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:2000536 | negative regulation of entry of bacterium into host cell | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0003697 | single-stranded DNA binding | 1.65e-03 | 1.00e+00 | 5.028 | 2 | 5 | 68 |
GO:0034683 | integrin alphav-beta3 complex | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0034686 | integrin alphav-beta8 complex | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0001846 | opsonin binding | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:1990430 | extracellular matrix protein binding | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0046456 | icosanoid biosynthetic process | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0034684 | integrin alphav-beta5 complex | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0005515 | protein binding | 2.00e-03 | 1.00e+00 | 1.019 | 11 | 184 | 6024 |
GO:0016020 | membrane | 2.06e-03 | 1.00e+00 | 1.986 | 6 | 90 | 1681 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 2.11e-03 | 1.00e+00 | 4.849 | 2 | 7 | 77 |
GO:0036462 | TRAIL-activated apoptotic signaling pathway | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0006458 | 'de novo' protein folding | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0044281 | small molecule metabolic process | 3.00e-03 | 1.00e+00 | 2.196 | 5 | 58 | 1211 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0006663 | platelet activating factor biosynthetic process | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0035877 | death effector domain binding | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0032369 | negative regulation of lipid transport | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 3 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0035965 | cardiolipin acyl-chain remodeling | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0006690 | icosanoid metabolic process | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 2 | 5 |
GO:0000730 | DNA recombinase assembly | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0032025 | response to cobalt ion | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0003688 | DNA replication origin binding | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 2 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0031265 | CD95 death-inducing signaling complex | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 3 | 6 |
GO:0031264 | death-inducing signaling complex | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0050764 | regulation of phagocytosis | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0060546 | negative regulation of necroptotic process | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0033690 | positive regulation of osteoblast proliferation | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0000028 | ribosomal small subunit assembly | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0010888 | negative regulation of lipid storage | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 7 |
GO:0047498 | calcium-dependent phospholipase A2 activity | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0097342 | ripoptosome | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0031994 | insulin-like growth factor I binding | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0007596 | blood coagulation | 7.04e-03 | 1.00e+00 | 2.871 | 3 | 18 | 455 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 2 | 8 |
GO:0097202 | activation of cysteine-type endopeptidase activity | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 8 |
GO:0045116 | protein neddylation | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 2 | 8 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 4 | 8 |
GO:0051604 | protein maturation | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 8 |
GO:0097284 | hepatocyte apoptotic process | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 3 | 9 |
GO:0036150 | phosphatidylserine acyl-chain remodeling | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 9 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 10 |
GO:0043032 | positive regulation of macrophage activation | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 10 |
GO:0001841 | neural tube formation | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 10 |
GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0032727 | positive regulation of interferon-alpha production | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0009395 | phospholipid catabolic process | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 4 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0004623 | phospholipase A2 activity | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0036149 | phosphatidylinositol acyl-chain remodeling | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0004622 | lysophospholipase activity | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0071236 | cellular response to antibiotic | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0005730 | nucleolus | 1.11e-02 | 1.00e+00 | 1.757 | 5 | 69 | 1641 |
GO:0032403 | protein complex binding | 1.14e-02 | 1.00e+00 | 3.600 | 2 | 10 | 183 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 2 | 13 |
GO:0043277 | apoptotic cell clearance | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0005662 | DNA replication factor A complex | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 3 | 13 |
GO:0001530 | lipopolysaccharide binding | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 3 | 13 |
GO:0050482 | arachidonic acid secretion | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0001525 | angiogenesis | 1.24e-02 | 1.00e+00 | 3.538 | 2 | 4 | 191 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 4 | 14 |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 14 |
GO:0042026 | protein refolding | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 15 |
GO:0031528 | microvillus membrane | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 15 |
GO:0050431 | transforming growth factor beta binding | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 15 |
GO:0005123 | death receptor binding | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 15 |
GO:0030101 | natural killer cell activation | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 3 | 16 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 16 |
GO:0031258 | lamellipodium membrane | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 16 |
GO:0050998 | nitric-oxide synthase binding | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 16 |
GO:0031589 | cell-substrate adhesion | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 16 |
GO:0031527 | filopodium membrane | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 17 |
GO:0050919 | negative chemotaxis | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 17 |
GO:0070371 | ERK1 and ERK2 cascade | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 17 |
GO:0050870 | positive regulation of T cell activation | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 17 |
GO:0046718 | viral entry into host cell | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 18 |
GO:0050840 | extracellular matrix binding | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0035861 | site of double-strand break | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0007088 | regulation of mitosis | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0036151 | phosphatidylcholine acyl-chain remodeling | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.70e-02 | 1.00e+00 | 5.868 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 1.70e-02 | 1.00e+00 | 5.868 | 1 | 1 | 19 |
GO:0032733 | positive regulation of interleukin-10 production | 1.70e-02 | 1.00e+00 | 5.868 | 1 | 1 | 19 |
GO:0097194 | execution phase of apoptosis | 1.70e-02 | 1.00e+00 | 5.868 | 1 | 1 | 19 |
GO:0034113 | heterotypic cell-cell adhesion | 1.70e-02 | 1.00e+00 | 5.868 | 1 | 1 | 19 |
GO:0005680 | anaphase-promoting complex | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 4 | 20 |
GO:0006298 | mismatch repair | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 3 | 20 |
GO:0042100 | B cell proliferation | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 1 | 21 |
GO:0006654 | phosphatidic acid biosynthetic process | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 1 | 21 |
GO:0045862 | positive regulation of proteolysis | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 1 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 4 | 21 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 5 | 21 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 3 | 22 |
GO:0030863 | cortical cytoskeleton | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 4 | 22 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 1 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 4 | 23 |
GO:0005844 | polysome | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 4 | 23 |
GO:0008305 | integrin complex | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 1 | 23 |
GO:0001968 | fibronectin binding | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 25 |
GO:0000722 | telomere maintenance via recombination | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 5 | 25 |
GO:0006281 | DNA repair | 2.23e-02 | 1.00e+00 | 3.088 | 2 | 18 | 261 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 3 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 25 |
GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 4 | 26 |
GO:0070979 | protein K11-linked ubiquitination | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 6 | 26 |
GO:0035987 | endodermal cell differentiation | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 1 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 3 | 26 |
GO:0009409 | response to cold | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 2 | 26 |
GO:0034612 | response to tumor necrosis factor | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 2 | 27 |
GO:0043022 | ribosome binding | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 3 | 27 |
GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 4 | 27 |
GO:0005743 | mitochondrial inner membrane | 2.49e-02 | 1.00e+00 | 3.002 | 2 | 8 | 277 |
GO:0019894 | kinesin binding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 1 | 28 |
GO:0001618 | virus receptor activity | 2.58e-02 | 1.00e+00 | 5.258 | 1 | 1 | 29 |
GO:0019005 | SCF ubiquitin ligase complex | 2.58e-02 | 1.00e+00 | 5.258 | 1 | 1 | 29 |
GO:0006271 | DNA strand elongation involved in DNA replication | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 7 | 30 |
GO:0005544 | calcium-dependent phospholipid binding | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 30 |
GO:0005164 | tumor necrosis factor receptor binding | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 30 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 30 |
GO:0005856 | cytoskeleton | 2.73e-02 | 1.00e+00 | 2.931 | 2 | 12 | 291 |
GO:0046677 | response to antibiotic | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 2 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 4 | 31 |
GO:0043234 | protein complex | 2.80e-02 | 1.00e+00 | 2.911 | 2 | 18 | 295 |
GO:0005245 | voltage-gated calcium channel activity | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 1 | 32 |
GO:0045335 | phagocytic vesicle | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 2 | 33 |
GO:0097110 | scaffold protein binding | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 3 | 34 |
GO:0001895 | retina homeostasis | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 1 | 34 |
GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 2 | 34 |
GO:0005876 | spindle microtubule | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 2 | 34 |
GO:0005737 | cytoplasm | 3.06e-02 | 1.00e+00 | 1.044 | 7 | 110 | 3767 |
GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 3 | 35 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 1 | 35 |
GO:0034332 | adherens junction organization | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 1 | 36 |
GO:0034446 | substrate adhesion-dependent cell spreading | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 2 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 2 | 36 |
GO:0007411 | axon guidance | 3.24e-02 | 1.00e+00 | 2.798 | 2 | 13 | 319 |
GO:0008234 | cysteine-type peptidase activity | 3.29e-02 | 1.00e+00 | 4.906 | 1 | 3 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.29e-02 | 1.00e+00 | 4.906 | 1 | 4 | 37 |
GO:0006284 | base-excision repair | 3.29e-02 | 1.00e+00 | 4.906 | 1 | 3 | 37 |
GO:0005813 | centrosome | 3.37e-02 | 1.00e+00 | 2.767 | 2 | 14 | 326 |
GO:0097191 | extrinsic apoptotic signaling pathway | 3.37e-02 | 1.00e+00 | 4.868 | 1 | 3 | 38 |
GO:0071407 | cellular response to organic cyclic compound | 3.37e-02 | 1.00e+00 | 4.868 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 3.37e-02 | 1.00e+00 | 4.868 | 1 | 2 | 38 |
GO:0000781 | chromosome, telomeric region | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 3 | 39 |
GO:0032729 | positive regulation of interferon-gamma production | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 2 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 3.46e-02 | 1.00e+00 | 4.830 | 1 | 4 | 39 |
GO:0045785 | positive regulation of cell adhesion | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 4 | 40 |
GO:0019369 | arachidonic acid metabolic process | 3.72e-02 | 1.00e+00 | 4.723 | 1 | 2 | 42 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 3.81e-02 | 1.00e+00 | 4.689 | 1 | 4 | 43 |
GO:0005080 | protein kinase C binding | 3.81e-02 | 1.00e+00 | 4.689 | 1 | 1 | 43 |
GO:0021762 | substantia nigra development | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 2 | 44 |
GO:0044297 | cell body | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 7 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 4.16e-02 | 1.00e+00 | 4.561 | 1 | 5 | 47 |
GO:0005925 | focal adhesion | 4.16e-02 | 1.00e+00 | 2.600 | 2 | 19 | 366 |
GO:0007155 | cell adhesion | 4.23e-02 | 1.00e+00 | 2.588 | 2 | 6 | 369 |
GO:0016049 | cell growth | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 1 | 49 |
GO:0003684 | damaged DNA binding | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 7 | 49 |
GO:0006986 | response to unfolded protein | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 2 | 50 |
GO:0005905 | coated pit | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 3 | 50 |
GO:0004197 | cysteine-type endopeptidase activity | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 3 | 50 |
GO:0003725 | double-stranded RNA binding | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 4.68e-02 | 1.00e+00 | 4.388 | 1 | 5 | 53 |
GO:0008233 | peptidase activity | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 2 | 54 |
GO:0045216 | cell-cell junction organization | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 2 | 54 |
GO:0097193 | intrinsic apoptotic signaling pathway | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 6 | 55 |
GO:0002039 | p53 binding | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 7 | 55 |
GO:0000724 | double-strand break repair via homologous recombination | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 3 | 55 |
GO:0051291 | protein heterooligomerization | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 2 | 56 |
GO:0009986 | cell surface | 4.93e-02 | 1.00e+00 | 2.465 | 2 | 11 | 402 |
GO:0000723 | telomere maintenance | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 6 | 56 |
GO:0051087 | chaperone binding | 5.19e-02 | 1.00e+00 | 4.233 | 1 | 6 | 59 |
GO:0006302 | double-strand break repair | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 4 | 62 |
GO:0019903 | protein phosphatase binding | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 4 | 62 |
GO:0030141 | secretory granule | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 2 | 62 |
GO:0071260 | cellular response to mechanical stimulus | 5.71e-02 | 1.00e+00 | 4.093 | 1 | 5 | 65 |
GO:0006289 | nucleotide-excision repair | 5.96e-02 | 1.00e+00 | 4.028 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 5.96e-02 | 1.00e+00 | 4.028 | 1 | 1 | 68 |
GO:0046474 | glycerophospholipid biosynthetic process | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 4 | 70 |
GO:0032587 | ruffle membrane | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 3 | 70 |
GO:0032355 | response to estradiol | 6.22e-02 | 1.00e+00 | 3.966 | 1 | 5 | 71 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 6 | 74 |
GO:0002020 | protease binding | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 2 | 75 |
GO:0044267 | cellular protein metabolic process | 6.62e-02 | 1.00e+00 | 2.227 | 2 | 29 | 474 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 6.64e-02 | 1.00e+00 | 3.868 | 1 | 3 | 76 |
GO:0007229 | integrin-mediated signaling pathway | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 2 | 78 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 3 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 6.89e-02 | 1.00e+00 | 3.812 | 1 | 3 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 3 | 80 |
GO:0019083 | viral transcription | 7.06e-02 | 1.00e+00 | 3.776 | 1 | 10 | 81 |
GO:0007160 | cell-matrix adhesion | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 3 | 82 |
GO:0047485 | protein N-terminus binding | 7.48e-02 | 1.00e+00 | 3.689 | 1 | 5 | 86 |
GO:0045471 | response to ethanol | 7.48e-02 | 1.00e+00 | 3.689 | 1 | 3 | 86 |
GO:0006415 | translational termination | 7.57e-02 | 1.00e+00 | 3.673 | 1 | 10 | 87 |
GO:0050821 | protein stabilization | 7.65e-02 | 1.00e+00 | 3.656 | 1 | 2 | 88 |
GO:0016605 | PML body | 7.65e-02 | 1.00e+00 | 3.656 | 1 | 3 | 88 |
GO:0006928 | cellular component movement | 7.90e-02 | 1.00e+00 | 3.608 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 7.90e-02 | 1.00e+00 | 3.608 | 1 | 8 | 91 |
GO:0071456 | cellular response to hypoxia | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 6 | 92 |
GO:0005634 | nucleus | 8.04e-02 | 1.00e+00 | 0.768 | 7 | 136 | 4559 |
GO:0006414 | translational elongation | 8.07e-02 | 1.00e+00 | 3.576 | 1 | 13 | 93 |
GO:0051082 | unfolded protein binding | 8.07e-02 | 1.00e+00 | 3.576 | 1 | 5 | 93 |
GO:0070588 | calcium ion transmembrane transport | 8.24e-02 | 1.00e+00 | 3.546 | 1 | 2 | 95 |
GO:0034142 | toll-like receptor 4 signaling pathway | 8.32e-02 | 1.00e+00 | 3.531 | 1 | 3 | 96 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 8.98e-02 | 1.00e+00 | 3.415 | 1 | 10 | 104 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 9.07e-02 | 1.00e+00 | 3.401 | 1 | 5 | 105 |
GO:0014069 | postsynaptic density | 9.07e-02 | 1.00e+00 | 3.401 | 1 | 3 | 105 |
GO:0005741 | mitochondrial outer membrane | 9.07e-02 | 1.00e+00 | 3.401 | 1 | 7 | 105 |
GO:0042127 | regulation of cell proliferation | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 3 | 109 |
GO:0002224 | toll-like receptor signaling pathway | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 3 | 109 |
GO:0005815 | microtubule organizing center | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 5 | 109 |
GO:0050900 | leukocyte migration | 9.48e-02 | 1.00e+00 | 3.334 | 1 | 1 | 110 |
GO:0015630 | microtubule cytoskeleton | 9.48e-02 | 1.00e+00 | 3.334 | 1 | 4 | 110 |
GO:0072562 | blood microparticle | 9.56e-02 | 1.00e+00 | 3.321 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 8 | 112 |
GO:0005819 | spindle | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 7 | 112 |
GO:0097190 | apoptotic signaling pathway | 9.72e-02 | 1.00e+00 | 3.295 | 1 | 6 | 113 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 9.81e-02 | 1.00e+00 | 3.283 | 1 | 11 | 114 |
GO:0045087 | innate immune response | 9.84e-02 | 1.00e+00 | 1.896 | 2 | 24 | 596 |
GO:0019058 | viral life cycle | 9.89e-02 | 1.00e+00 | 3.270 | 1 | 13 | 115 |
GO:0006325 | chromatin organization | 1.01e-01 | 1.00e+00 | 3.233 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 5 | 120 |
GO:0032496 | response to lipopolysaccharide | 1.04e-01 | 1.00e+00 | 3.197 | 1 | 4 | 121 |
GO:0006260 | DNA replication | 1.04e-01 | 1.00e+00 | 3.197 | 1 | 9 | 121 |
GO:0009615 | response to virus | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 5 | 126 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 5 | 126 |
GO:0016477 | cell migration | 1.09e-01 | 1.00e+00 | 3.116 | 1 | 5 | 128 |
GO:0030335 | positive regulation of cell migration | 1.09e-01 | 1.00e+00 | 3.127 | 1 | 7 | 127 |
GO:0006644 | phospholipid metabolic process | 1.10e-01 | 1.00e+00 | 3.104 | 1 | 5 | 129 |
GO:0000790 | nuclear chromatin | 1.10e-01 | 1.00e+00 | 3.104 | 1 | 9 | 129 |
GO:0006413 | translational initiation | 1.12e-01 | 1.00e+00 | 3.082 | 1 | 17 | 131 |
GO:0003735 | structural constituent of ribosome | 1.17e-01 | 1.00e+00 | 3.018 | 1 | 10 | 137 |
GO:0007507 | heart development | 1.18e-01 | 1.00e+00 | 2.997 | 1 | 7 | 139 |
GO:0016887 | ATPase activity | 1.19e-01 | 1.00e+00 | 2.986 | 1 | 7 | 140 |
GO:0006457 | protein folding | 1.22e-01 | 1.00e+00 | 2.956 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 1.23e-01 | 1.00e+00 | 2.936 | 1 | 7 | 145 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.23e-01 | 1.00e+00 | 2.936 | 1 | 4 | 145 |
GO:0005769 | early endosome | 1.29e-01 | 1.00e+00 | 2.868 | 1 | 2 | 152 |
GO:0045121 | membrane raft | 1.32e-01 | 1.00e+00 | 2.830 | 1 | 8 | 156 |
GO:0043005 | neuron projection | 1.33e-01 | 1.00e+00 | 2.821 | 1 | 6 | 157 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.39e-01 | 1.00e+00 | 2.749 | 1 | 7 | 165 |
GO:0030424 | axon | 1.40e-01 | 1.00e+00 | 2.741 | 1 | 4 | 166 |
GO:0009897 | external side of plasma membrane | 1.48e-01 | 1.00e+00 | 2.648 | 1 | 3 | 177 |
GO:0030168 | platelet activation | 1.70e-01 | 1.00e+00 | 2.436 | 1 | 10 | 205 |
GO:0007067 | mitotic nuclear division | 1.86e-01 | 1.00e+00 | 2.289 | 1 | 14 | 227 |
GO:0005759 | mitochondrial matrix | 1.87e-01 | 1.00e+00 | 2.283 | 1 | 14 | 228 |
GO:0006412 | translation | 1.89e-01 | 1.00e+00 | 2.270 | 1 | 20 | 230 |
GO:0004842 | ubiquitin-protein transferase activity | 2.07e-01 | 1.00e+00 | 2.121 | 1 | 6 | 255 |
GO:0005615 | extracellular space | 2.12e-01 | 1.00e+00 | 1.213 | 2 | 17 | 957 |
GO:0043065 | positive regulation of apoptotic process | 2.16e-01 | 1.00e+00 | 2.050 | 1 | 10 | 268 |
GO:0019899 | enzyme binding | 2.23e-01 | 1.00e+00 | 2.002 | 1 | 12 | 277 |
GO:0005739 | mitochondrion | 2.26e-01 | 1.00e+00 | 1.153 | 2 | 28 | 998 |
GO:0030198 | extracellular matrix organization | 2.27e-01 | 1.00e+00 | 1.971 | 1 | 4 | 283 |
GO:0006200 | ATP catabolic process | 2.34e-01 | 1.00e+00 | 1.926 | 1 | 15 | 292 |
GO:0016567 | protein ubiquitination | 2.36e-01 | 1.00e+00 | 1.911 | 1 | 5 | 295 |
GO:0044822 | poly(A) RNA binding | 2.46e-01 | 1.00e+00 | 1.071 | 2 | 49 | 1056 |
GO:0019901 | protein kinase binding | 2.51e-01 | 1.00e+00 | 1.807 | 1 | 21 | 317 |
GO:0008283 | cell proliferation | 2.59e-01 | 1.00e+00 | 1.758 | 1 | 14 | 328 |
GO:0003723 | RNA binding | 2.68e-01 | 1.00e+00 | 1.698 | 1 | 20 | 342 |
GO:0006508 | proteolysis | 2.92e-01 | 1.00e+00 | 1.553 | 1 | 9 | 378 |
GO:0046982 | protein heterodimerization activity | 2.93e-01 | 1.00e+00 | 1.546 | 1 | 13 | 380 |
GO:0008284 | positive regulation of cell proliferation | 2.95e-01 | 1.00e+00 | 1.538 | 1 | 8 | 382 |
GO:0005524 | ATP binding | 3.29e-01 | 1.00e+00 | 0.774 | 2 | 60 | 1298 |
GO:0005509 | calcium ion binding | 3.86e-01 | 1.00e+00 | 1.063 | 1 | 5 | 531 |
GO:0005789 | endoplasmic reticulum membrane | 4.08e-01 | 1.00e+00 | 0.961 | 1 | 16 | 570 |
GO:0005886 | plasma membrane | 4.19e-01 | 1.00e+00 | 0.366 | 3 | 45 | 2582 |
GO:0005794 | Golgi apparatus | 4.30e-01 | 1.00e+00 | 0.863 | 1 | 15 | 610 |
GO:0005887 | integral component of plasma membrane | 5.62e-01 | 1.00e+00 | 0.321 | 1 | 6 | 888 |
GO:0008270 | zinc ion binding | 6.06e-01 | 1.00e+00 | 0.154 | 1 | 12 | 997 |
GO:0046872 | metal ion binding | 7.09e-01 | 1.00e+00 | -0.236 | 1 | 25 | 1307 |